Amalgamated Bank Immunity Bio, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 5,268 shares of IBRX stock, worth $11,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,268
Previous 5,268
-0.0%
Holding current value
$11,273
Previous $13,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IBRX
# of Institutions
285Shares Held
130MCall Options Held
2.53MPut Options Held
3.02M-
Vanguard Group Inc Valley Forge, PA27.7MShares$59.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$24.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$18.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$16.6 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$16.5 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $857M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...